NLS Pharmaceutics Ltd (NLSP)
0.1341
0.00 (0.00%)
USD |
NASDAQ |
May 02, 10:29
NLS Pharmaceutics Total Assets (Quarterly): 2.270M for June 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 2.270M |
| June 30, 2023 | 2.270M |
| December 31, 2022 | 9.277M |
| June 30, 2022 | 2.058M |
| June 30, 2022 | 2.058M |
| December 31, 2021 | 5.765M |
| June 30, 2021 | 8.269M |
| June 30, 2021 | 8.269M |
| Date | Value |
|---|---|
| December 31, 2020 | 1.212M |
| June 30, 2020 | 0.64M |
| June 30, 2020 | 0.64M |
| December 31, 2019 | 0.6964M |
| June 30, 2019 | 1.374M |
| June 30, 2019 | 1.374M |
| December 31, 2018 | 0.1456M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.64M
Minimum
Jun 2020
9.277M
Maximum
Dec 2022
3.298M
Average
2.058M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| AC Immune SA | 217.65M |
| CRISPR Therapeutics AG | 2.230B |
| Addex Therapeutics Ltd | 5.526M |
| Molecular Partners AG | 236.15M |
| MoonLake Immunotherapeutics | 526.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.557M |
| Shareholders Equity (Quarterly) | -4.287M |